Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy

Pathophysiology

Volumn 11, Issue 2, 2004, Pages 95-101

  Maniscalco, Benedict S ^a   Taylor, Karen A ^a  

^a Suite 201 ^*  (United States)

Author keywords

Calcification; Coronary artery disease; Infection; Nanobacteria

Indexed keywords

ANTICOAGULANT AGENT; ARGININE; ASCORBIC ACID; BACTERIAL ANTIGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMELAIN; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CRATAEGUS EXTRACT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EDETIC ACID; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LYSINE; NICOTINIC ACID; NITRATE; ORNITHINE; PAPAIN; PLANT EXTRACT; PYRIDOXINE; SELENIUM; TETRACYCLINE; TRYPSIN; UBIDECARENONE;

ADULT; AGED; ANGINA PECTORIS; ANTIGEN DETECTION; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIUM; BLOOD CELL COUNT; BLOOD TOXICITY; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; FEMALE; GRAPE; HUMAN; LIPID ANALYSIS; LIVER FUNCTION TEST; LIVER TOXICITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLISM; NEPHROTOXICITY; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; SEROLOGY; SIDE EFFECT; STOMACH PAIN; TREATMENT OUTCOME;

EID: 4444241959     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2004.06.001     Document Type: Article

References (27)

1. Libby P., Ridker P., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135-1143
2. Zeiher A.M., Goebel H., Schachinger V., Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation. 91:1995;941-947
3. O'Brien E.R., Garvin M.R., Dev R., Stewart D.K., Hinohara T., Simpson J.B., Schwartz S.M. Angiogenesis in human coronary atherosclerotic plaques. Am J. Pathol. 145:1994;883-894
4. Tenaglia A.N., Peters K.G., Sketch M.H. Jr., Annex B.H. Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. Am. Heart J. 135:1998;10-14
5. Nair A., Kuban B.D., Tuzcu E.M., Schoenhagen P., Nissen S.E., Vince D.G. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. 106:2002;2200-2206
6. Yoon H.C., Emerick A.M., Hill J.A., Gjertson D.W., Golding J.G. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. Radiology. 224:2002;236-241
7. Raggi P., Cooil B., Shaw L.J., Aboulhson J., Takasu J., Budoff M., Callister T.G. Progression of coronary calsium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am. J. Cardiol. 92:2003;827-829
8. Budoff M.J., Lane K.L., Bakhsheshi H., Mao S., Grassmann B.O., Friedman B.C., Brundage B.H. Rates of progression of coronary calcium by electron beam tomography. Am. J. Cardiol. 86:2000;8-11
9. Nasir K., Budoff M.J., Post W.S., Fisherman E.K., Mahesh M., Lima J.A., Blumenthal R.S. Electron beam CT versus helical CT scans for assessing coronary calcification: current utility and future directions. Am. Heart J. 146:2003;969-977
10. Janowitz W.R. CT imaging of coronary artery calcium as an indicator of atherosclerotic disease: an overview. J. Thorac. Imaging. 16:2001;2-7
11. Zhu J., Katz R.J., Quyyumi A.A., Canos D.A., Rott D., Csako G., Zalles-Ganley A., Ogunmakinwa J., Wasserman A.G., Epstein S.E. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels. Suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation. 109:2004;36-41
12. Kajander E.O., Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8274-8279
13. Kajander E.O., Ciftcioglu N., Aho K., Garcia-Cuerpo E. Characteristics of nanobacteria and their possible role in stone formation. Urol. Res. 31:2003;47-54
14. Ciftcioglu N., McKay D.S., Kajander E.O. Association between nanobacteria and periodontal disease. Circulation. 108:2003;E58-E59
15. Maniscalco B.S. Shouldering the risk burden: infection, atherosclerosis, and the vascular endothelium. Circulation. 107:2003;E74
16. E.O. Kajander, K.M. Aho, B.S. Maniscalco, G.S. Mezo, The Pathogenesis of Vascular Calcification, New Clinical Diagnostic Markers and a New Curative Nanobiotic Treatment for Reversing Atherosclerosis in Humans, in: S. Anttila, J. Antonen, N. Hutri-Kähönen, J. Lahtela, E. Tomas, P. Anttila (Eds.), XXIV Tampereen Lääkäripäivät 20-22.3, Luennot XXIV, Lege Artis Oy, Tampere, 2003, p. 330.
17. L. Puskas, L. Tiszlavicz, L. Torday, J. Papp, Detection of nanobacteria in human atherosclerotic plaques. International Nanobacteria Minisymposium, 8 March 2001, Kuopio, Book of abstracts, Kuopio University Press, Kuopio, (in press). Abstract published online at http://www.nanobac.com/nbminisymp080301.
18. V.M. Miller, G. Rodgers, J.A. Charlesworth, B. Kirkland, S.R. Severson, T.E. Rasmussen, M. Yagubyan, J.C. Rodgers, F.R. Cockerill, R.L. Folk,V. Kumar, G. Farell-Baril, J.C. Lieske, Evidence of Nanobacterial-like Structures in Human Calcified Arteries and Cardiac Valves, Am. J. Physiol. Heart Circ. Physiol., 2004. doi: 10.1152/ajpheart.00075.2004
19. Jelic T.M., Malas A.M., Groves S.S., Jin B., Mellen P.F., Osborne G., Roque R., Rosencrance J.G., Chang H.H. Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med. J. 97:2004;194-198
20. Hsu H.H.T., Camacho N.P., Sun F., Tawfik O., Aono H. Isolation of calcifiable vesicles from aortas of rabbits fed with high cholesterol diets. Atherosclerosis. 153:2000;337-348
21. Hjelle J.T., Miller-Hjelle M.A., Poxton I.R., Kajander E.O., Ciftcioglu N., Jones M.L., Caughey R.C., Brown R., Millikin P.D., Darras F.S. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int. 57:2000;2360-2374
22. Ciftcioglu N., Miller-Hjelle M.A., Hjelle J.T., Kajander E.O. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob. Agents Chemother. 46:2002;2077-2086
23. Ciftcioglu N., Kajander E.O. Interaction of nanobacteria with cultured mammalian cells. Pathophysiology. 4:1998;59-70
24. K. Seppanen, P. Soininen, J.T. Salonen, S. Lotjonen, R. Laatikainen, Does mercury promote lipid peroxidation? An in vitro study concerning mercury, copper and iron peroxidation of low density lipoprotein, Biol. Trace Elem. Res., in press.
25. Uhl H.S., Dysk R.C., St Clair R.W. EDTA reduces liver cholesterol content in cholesterol-fed rabbits. Atherosclerosis. 96:1992;181-188
26. Evans D.A., Tariq M., Sujata B., McCann G., Sobki S. The effects of magnesium sulphate and EDTA in the hypercholesterolaemic rabbit. Diabetes Obes. Metab. 3:2001;417-422
27. Sierevogel M.J., Pasterkamp G., de Kleijn D.P., Strauss B.H. Matrix metalloproteinases: a therapeutic target in cardiovascular disease. Curr. Pharm. Des. 9:2003;1033-1040